Key result
In-stent neoatherosclerosis was observed in 76.7% of symptomatic lower extremity in-stent restenosis lesions, with all stents implanted >5 years showing signs of neoatherosclerosis.
Why the study?
Little is known about the role of in-stent neoatherosclerosis in stent failure and in-stent restenosis in lower limb arteries.
What is the prevalence and pattern of in-stent neoatherosclerosis assessed by OCT in patients with symptomatic lower extremity artery disease and in-stent restenosis?
Observational (n=24)
What is the prevalence and pattern of in-stent neoatherosclerosis assessed by OCT in patients with symptomatic lower extremity artery disease and in-stent restenosis?
In-stent neoatherosclerosis is frequently identified by OCT in lower limb arteries with in-stent restenosis, and its frequency and extent increase with longer duration since implantation.
Answers are grounded in this paper and cite their sources.
Frequent neoatherosclerosis in long-implanted lower-limb stents supports OCT assessment in ISR; hypothesis-generating and should not yet change practice.
BACKGROUND: In-stent restenosis (ISR) is responsible for a rapid decline of vessel patency after stenting. To date, little is known about the role of in-stent neoatherosclerosis (NA) in stent failure in lower limb arteries. AIMS: This study aimed to determine the prevalence and patterns of in-stent NA in patients with symptomatic ISR of the lower extremity vasculature using intravascular optical coherence tomography (OCT) imaging. METHODS: Patients underwent endovascular revascularisation for ISR including angiography and OCT imaging. NA was defined as the presence of at least 1 fibroatheroma or fibrocalcific plaque within the neointima of a stented segment. RESULTS: Using OCT, we imaged 24 symptomatic patients with lower extremity artery disease (LEAD), with a total of 30 ISR in the lower limbs, prior to their scheduled endovascular interventions. NA formation was observed in 23 (76.7%) lesions, while all stents with an implant duration >5 years (n=8) showed signs of NA. The time from stent implantation to OCT was significantly increased in lesions with NA (p=0.002). Lesions without NA had a significantly shorter duration from index procedure to OCT than those with ≥50 percent (n=9; p=0.003) or <50 percent (n=14; p=0.015) of frames exhibiting signs of NA. NA was predominantly characterised by fibroatheroma with thick fibrous caps with or without calcification. CONCLUSIONS: In-stent NA is frequently identified by OCT imaging after endovascular therapy in lower limb arteries; this increased both in frequency and extent the longer the duration since implantation. Our findings indicate an active atherosclerotic process that may need tailored mitigation strategies.
No takes yet. Share an insight, caveat, or question.
Müller et al. (2023) conducted an observational in Lower extremity artery disease with symptomatic in-stent restenosis (n=24). Stent implantation in lower extremity arteries was evaluated on Prevalence of in-stent neoatherosclerosis (NA) in stented segments. In-stent neoatherosclerosis was observed in 76.7% of symptomatic lower extremity in-stent restenosis lesions, with all stents implanted >5 years showing signs of neoatherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: